SEVENTH LOAN MODIFICATION AGREEMENTLoan Modification Agreement • June 15th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
This Seventh Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of June 14, 2016, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at One Main Street, 8th Floor, Cambridge, Massachusetts 02142 (“Borrower”).
VOTING AGREEMENTVoting Agreement • June 15th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT (this “Voting Agreement”), dated as of June 14, 2016, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (“Aegerion”), and [ ], a [ ] (the “Shareholder”).
FOURTH AMENDMENT TO FORBEARANCE AGREEMENTForbearance Agreement • June 15th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO FORBEARANCE AGREEMENT (this “Amendment”) is made as of this 8th day of June, 2016 by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at One Main Street, 8th Floor, Cambridge, Massachusetts 02142 (“Borrower”).
SUBORDINATION AGREEMENTSubordination Agreement • June 15th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Subordination Agreement (the “Agreement”) is made as of June 14, 2016, by and between QLT INC. (“Creditor”), and SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 (“Bank”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG AEGERION PHARMACEUTICALS, INC., QLT INC. AND ISOTOPE ACQUISITION CORP. June 14, 2016Merger Agreement • June 15th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
WARRANT AGREEMENT (this “Agreement”), dated as of [·], 2016, among QLT Inc., a corporation incorporated under the laws of British Columbia (the “Company”), and Computershare Trust Company of Canada, a trust company licensed to carry on business in all Provinces in Canada (the “Warrant Agent”).
